Bristol Myers Squibb to Implement Claude as Shared Intelligence Platform Across its Global Operations
Publish Date: 2026-05-20 13:14:00
Source Domain: njbmagazine.com
- On May 20, 2026, Bristol Myers Squibb announced a collaboration with AI company Anthropic to integrate Claude across all its business functions.
- The collaboration aims to enhance AI capabilities beyond conversational tools to include advanced reasoning and agentic capabilities within daily workflows.
- Three areas of focus are identified: engineering, drug development, and manufacturing & quality, with expected significant near-term impacts.
- BMS plans to empower over 30,000 employees using Claude Code and agents to accelerate research, streamline trial documentation, and improve manufacturing processes.
- The deployment connectsClaude to institutional knowledge bases across BMS, ensuring secure and regulated use while activating valuable expert knowledge.
- This initiative builds on over three years of substantial AI investment by BMS, establishing the company as a leader in AI integration in research, clinical development, manufacturing, and commercial functions.
